Stocks
ABIO Financial Statements (ABIO) |
||||||||||
| Артген биотех (ИСКЧ)smart-lab.ru | % | 2022Q2 | 2022Q4 | 2023Q1 | 2023Q2 | 2023Q4 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 29.08.2022 | 29.04.2023 | 30.08.2023 | 30.08.2023 | ||||||
| Currency | RUB | RUB | RUB | RUB | RUB | RUB | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 0.520 | 0.616 | 0.620 | 1.24 | |||||
| Operating Income, bln rub | 0.065 | 0.046 | 0.105 | 0.151 | ||||||
| EBITDA, bln rub | ? | 0.100 | 0.064 | 0.150 | 0.214 | |||||
| Net profit, bln rub | ? | 0.025 | 0.020 | 0.032 | 0.052 | |||||
| OCF, bln rub | ? | 0.047 | 0.173 | 0.052 | 0.225 | |||||
| CAPEX, bln rub | ? | 0.097 | 0.121 | 0.065 | 0.186 | |||||
| FCF, bln rub | ? | -0.091 | 0.049 | -0.077 | -0.028 | |||||
| Dividend payout, bln rub | 0.085 | 0.111 | 0.111 | |||||||
| Dividend, rub/share | ? | 1 | 1.2 | 1.2 | ||||||
| Ordinary share dividend yield, % | 0.0% | 1.6% | 0.0% | 0.0% | 1.2% | 1.3% | ||||
| Dividend payout ratio, % | 0% | 425% | 0% | 213% | ||||||
| OPEX, bln rub | 0.456 | 0.570 | 0.516 | 1.09 | ||||||
| Amortization, bln rub | 0.0 | 0.0 | 0.0 | |||||||
| Interest expenses, bln rub | 0.035 | 0.020 | 0.054 | 0.074 | ||||||
| Assets, bln rub | 1.75 | 2.04 | 2.36 | 2.36 | ||||||
| Net Assets, bln rub | ? | 0.276 | 0.341 | 0.381 | 0.381 | |||||
| Debt, bln rub | 0.506 | 0.708 | 0.673 | 0.673 | ||||||
| Cash, bln rub | 0.060 | 0.202 | 0.362 | 0.362 | ||||||
| Net debt, bln rub | 0.45 | 0.51 | 0.00 | 0.31 | 0.00 | 0.31 | ||||
| Ordinary share price, rub | 57.8 | 62.1 | 116.3 | 104.0 | 102.0 | 94.2 | ||||
| Number of ordinary shares, mln | 85.0 | 92.6 | 92.6 | 92.6 | 92.6 | 92.6 | ||||
| Market cap, bln rub | 4.92 | 5.75 | 10.8 | 9.64 | 9.45 | 8.73 | ||||
| EV, bln rub | ? | 5.36 | 6.26 | 10.8 | 9.95 | 9.45 | 9.04 | |||
| Book value, bln rub | -0.30 | -0.40 | 0.00 | -0.36 | 0.00 | -0.36 | ||||
| EPS, rub | ? | 0.29 | 0.22 | 0.00 | 0.35 | 0.00 | 0.56 | |||
| FCF/share, rub | -1.07 | 0.53 | 0.00 | -0.83 | 0.00 | -0.30 | ||||
| BV/share, rub | -3.54 | -4.26 | 0.00 | -3.92 | 0.00 | -3.92 | ||||
| EBITDA margin, % | ? | 19.2% | 10.4% | 24.2% | 17.3% | |||||
| Net margin, % | ? | 4.8% | 3.2% | 5.2% | 4.2% | |||||
| FCF yield, % | ? | -0.1% | -0.7% | -0.4% | -0.3% | -0.8% | -0.3% | |||
| ROE, % | ? | 14.1% | 13.2% | 13.6% | 13.6% | |||||
| ROA, % | ? | 2.2% | 2.2% | 2.2% | 2.2% | |||||
| P/E | ? | 126.1 | 127.8 | 239.4 | 185.3 | 295.3 | 167.9 | |||
| P/FCF | -54.0 | -136.9 | -125.2 | -122.7 | -311.8 | |||||
| P/S | ? | 4.30 | 5.06 | 9.48 | 7.80 | 15.2 | 7.06 | |||
| P/BV | ? | -16.3 | -14.6 | -26.5 | -24.0 | |||||
| EV/EBITDA | ? | 34.6 | 38.1 | 65.7 | 46.5 | 63.0 | 42.2 | |||
| Debt/EBITDA | 2.88 | 3.09 | 0.00 | 1.45 | 0.00 | 1.45 | ||||
| R&D/CAPEX, % | 0.00% | 0.00% | 0.00% | 0 | ||||||
| CAPEX/Revenue, % | 19% | 20% | 10% | 15% | ||||||
| Financial statement quality | 4 | |||||||||
| Investor Presentations | 3 | |||||||||
| Smart-lab presence | 1 | |||||||||
| Annual report | 3 | |||||||||
| Investor site URL | 4 | |||||||||
| Investor calendar | 4 | |||||||||
| ABIO shareholders | ||||||||||
